The generic industry is a changing landscape; the GPA team of experts, its partners and its international network of specialists are able to help navigate a path to success for both industry operators and institutions investing in it.
The team has experience at the very highest level and is able to advise on all aspects of commercial planning and operations. We work on projects at a global strategic level, but can also provide practical input at a local level.
Strategy
- Creating a successful ‘generic’ business
- Business design & modelling (vanilla, branded & hybrids)
- Internationalisation options
- Competitor analysis (analytical process & models)
- Buy, build or partner decisions
Products & Portfolio’s
- Maximising product value
- Portfolio valuations & international analysis
- Portfolio development & growth tactics
- Licensing, partnerships & collaborations (local, regional, international)
International Markets
- Country-by-country expert reports
- Current and forecast operating models
- Opportunity and threat analysis
- Pricing models
- M&A/JV targets
Legal & Regulatory
- Building strategy into product development
- Creating IP driven business models
- Paragraph IV & authorised generics
- International regulatory planning
Finance
- Creating a price competitive company
- Optimising assets for the generic sector
- Utilisation of manufacturing infrastructure
- Mergers & acquisitions
- Raising investment capital
Operational Support
- Due diligence (dossiers, manufacturing facilities, IP, contracts)
- Regulatory submissions, Pharmacovigilence systems, Tech transfers
- Pricing analysis & tactics
- Partner & supplier profiling
Profiles of the growing GPA team of experts